A drug discovery in the biotech company, Greenstone Biosciences, Inc (https://greenstonebio.com/) is using its unique drug discovery pipeline comprised of machine learning, virtual screening of chemical libraries, molecular docking, high throughput multi-omics sequencing, and human derived induced pluripotent stem cell technologies (hiPSCs). With the effort is to develop novel drug therapeutics to achieve precision medicine and precision health, Greenstone Biosciences is headquartered in the Alexandria Center for Life Science at Stanford Research Park in Palo Alto, CA. Human iPS cells, stem cells, cardiac cells, experience with handling mice and drug discovery research.
